WHO’s New Ethical Framework for Pathogen Surveillance: Balancing Global Health and Data Sovereignty
GS4GS2
The World Health Organization has introduced the first-ever ethical guidelines for pathogen genomic surveillance, addressing critical issues of equity and benefit-sharing. This framework aims to ensure that the global sharing of genetic data does not disadvantage the nations providing the samples.
The World Health Organization (WHO) has released a landmark guidance document titled 'Ethical Conduct of Pathogen Surveillance.' This is the first global framework designed to navigate the complex ethical landscape of sharing genetic data of pathogens, such as viruses and bacteria. The guidance arrives in the wake of the COVID-19 pandemic, which exposed significant gaps in how biological data is collected, shared, and utilized across borders.
At the heart of these guidelines are the principles of equity, benefit-sharing, and sovereignty. Historically, a 'data-benefit gap' has existed where developing nations in the Global South provide critical pathogen samples and genetic sequences, only to find the resulting vaccines, diagnostics, and treatments are either unaffordable or unavailable to them. The WHO framework emphasizes that pathogen surveillance must not be an extractive process. Instead, it should be a collaborative effort where the benefits of research are shared fairly with the communities and countries that provide the data.
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.